Loyal is a clinical-stage veterinary medicine company working on giving dogs longer, healthier lives.
Total raised: $72M
Investors 13
Show more
Funding Rounds 2
| Date | Series | Amount | Investors |
| 21.03.2024 | Series B | $45M | - |
| 23.09.2021 | - | $27M | - |
Mentions in press and media 13
| Date | Title | Description |
| 25.03.2024 | Loyal Raises $45M in Series B Financing | Loyal, a biotech company in San Francisco, has secured $45 million in Series B funding to develop drugs for dogs. Led by CEO Celine Halioua, the company aims to extend the lifespan of dogs by targeting the mechanisms of aging. With three dr... |
| 21.03.2024 | Loyal Raises $45M in Series B Financing | Dr. Ellen Ratcliff, Veterinarian and Director of Clinical Development at Loyal, with Boston, a seven-year-old Beagle mix. Loyal today announced $45 million in new funding. (Photo: Business Wire) Loyal, a San Francisco, CA-based biotech comp... |
| 21.03.2024 | Loyal raises $45 million | Loyal, a biotech startup on a mission to increase the life span of dogs, has raised $45 million in a Series B round led by Bain Capital Ventures. This brings total funding raised by Loyal to more than $125 million and includes a $12 million... |
| 01.02.2024 | The first anti-aging pill for dogs is entering trials — and an 11-year-old whippet named Boo is the first to try it | Health The first anti-aging pill for dogs is entering trials — and an 11-year-old whippet named Boo is the first to try it Hilary Brueck 2024-02-01T16:01:01Z Share icon An curved arrow pointing right. Share Facebook Icon The letter F. Faceb... |
| 28.11.2023 | An anti-aging drug for dogs promises to win owners more time with old pets. It could be FDA-approved soon. | Celine Halioua founded a biotech startup developing drugs to extend dog lifespans. Courtesy of Loyal Redeem now Loyal is developing drugs to extend doggie lifespans. One drug just cleared a key FDA hurdle, a sign the agency is ready to take... |
| 17.08.2023 | Startup is developing a pill intended to help large dogs live longer | San Francisco-based Loyal is working on a new drug it hopes will help large dogs live healthier, longer lives. Driving the news: Loyal recently partnered with pharmaceutical company Crinetics to get exclusive veterinary access to its compou... |
| 19.01.2022 | How Arab Women Are Making Waves In Tech | multi-ethnic businesswomen getty |
| 23.09.2021 | Loyal raises $27M, aims to give dog owners more time with their pets | San Francisco startup Loyal is rethinking the concept of longevity and starting with man’s best friend. The company raised $27 million in Series A funding in a round, led by Khosla Ventures and including First Round Capital, Box Group, Coll... |
| 23.09.2021 | How Toast came back from the brink | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Paid Content Why the Electricity 4.0 moment is here From Schneider Electric A year and a half ago... |
| 23.09.2021 | How Toast came back from the brink | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. A year and a half ago, restaurant software maker Toast laid off nearly half its workforce and fur... |
Show more